1-866-647-3279

21

Aug 2026

Health Canada Expands the List of Interchangeable Terms for NHP Labelling
Health Canada Expands the List of Interchangeable Terms for NHP Labelling
By
At a Glance Health Canada’s Natural and Non-prescription Health Products Directorate (NNHPD) has updated its List of Interchangeable Terms to provide greater flexibility when labelling Natural Health Products (NHPs) and […] Read More >>

19

Aug 2026

Clinical Supply Chain Oversight for Live Biotherapeutic Trials: Protecting Product Viability from Manufacturing to Patient
Clinical Supply Chain Oversight for Live Biotherapeutic Trials: Protecting Product Viability from Manufacturing to Patient
By
At a Glance Live Biotherapeutic Products (LBPs) are transforming therapeutic development, with clinical programs expanding across gastrointestinal disorders, metabolic disorders, immunology, oncology, and rare conditions. Unlike conventional pharmaceutical Read More >>

14

Aug 2026

What Is Vanessa’s Law and How Does It Impact Therapeutic Products in Canada?
What Is Vanessa’s Law and How Does It Impact Therapeutic Products in Canada?
By
At a Glance Vanessa’s Law, formally known as the Protecting Canadians from Unsafe Drugs Act, strengthened Health Canada’s authority to identify and respond to safety risks associated with therapeutic products […] Read More >>

14

Aug 2026

Postbiotics vs. Probiotics: Regulatory and Clinical Differences
Postbiotics vs. Probiotics: Regulatory and Clinical Differences
By
Abstract Probiotics and postbiotics are both increasingly used in microbiome-focused health products, but the regulatory and clinical considerations surrounding them can differ substantially. Probiotics depend on live microorganisms, making strain [&hellip Read More >>

14

Aug 2026

Health Canada Publishes New Guidance for Non-Prescription Drug Market Authorization in Canada
Health Canada Publishes New Guidance for Non-Prescription Drug Market Authorization in Canada
By
At a Glance Health Canada has released a new guidance document, How to apply for market authorization for a non-prescription drug in Canada, providing industry with its first comprehensive roadmap […] Read More >>

06

Aug 2026

What Is NHP Stability Testing? Understanding Shelf Life, Expiry Dates, and Health Canada Requirements
What Is NHP Stability Testing? Understanding Shelf Life, Expiry Dates, and Health Canada Requirements
By
At a Glance Stability testing is the process of evaluating how the quality of a dietary supplement or Natural Health Product (NHP) changes over time under defined storage conditions. The […] Read More >>

06

Aug 2026

AI in Regulatory Intelligence and Literature Reviews: Where It Helps, and Where It Falls Short
AI in Regulatory Intelligence and Literature Reviews: Where It Helps, and Where It Falls Short
By
At a Glance AI literature review tools can help regulatory and scientific teams search, screen, organize, and summarize growing volumes of information. Their greatest value lies in narrow, repetitive tasks […] Read More >>

06

Aug 2026

Adverse Event Monitoring in Probiotic Clinical Trials: What Sponsors Need to Get Right
Adverse Event Monitoring in Probiotic Clinical Trials: What Sponsors Need to Get Right
By
At a Glance While many commercially available probiotics have a well-documented history of safe use in healthy populations, clinical trials evaluating live biotherapeutic products (LBPs) or probiotic dietary supplements are […] Read More >>

31

Jul 2026

Cosmetic Claims in Canada: What Cosmetic Companies Can (and Can’t) Say
Cosmetic Claims in Canada: What Cosmetic Companies Can (and Can’t) Say
By
At a Glance Marketing claims are one of the most important factors determining how a cosmetic product is regulated in Canada. While cosmetics may claim to cleanse, beautify, moisturize, or […] Read More >>

21

Jul 2026

Health Canada’s New Draft Quality Guide for Natural Health Products: Open for Consultation
Health Canada’s New Draft Quality Guide for Natural Health Products: Open for Consultation
By
At a Glance Health Canada has released a draft Quality of Natural Health Products Guide for consultation, proposing the most significant update to NHP quality guidance since the finalized Good […] Read More >>

15

Jul 2026

Synbiotics: Regulatory Classification and Clinical Trial Considerations
Synbiotics: Regulatory Classification and Clinical Trial Considerations
By
Abstract Synbiotics represent an increasingly sophisticated approach to microbiome-focused products by combining live microorganisms with substrates designed to support beneficial microbial activity. However, regulatory classification and evidence requirem Read More >>

15

Jul 2026

Postbiotics: The “Non-Live” Microbe Trend Reshaping Functional Health Products
Postbiotics: The “Non-Live” Microbe Trend Reshaping Functional Health Products
By
Abstract Postbiotics are emerging as a significant new category of microbiome-focused products, offering potential advantages over traditional probiotics through improved stability, simplified manufacturing, and greater formulation flexibility. However, de Read More >>

15

Jul 2026

Does GRAS Status Matter in Canada?
Does GRAS Status Matter in Canada?
By
Abstract U.S. GRAS status is an important safety milestone, but it does not authorize an ingredient for sale in Canada. Instead, Health Canada evaluates ingredients under its own regulatory framework, […] Read More >>

14

Jul 2026

Front-of-Package Nutrition Labelling Is Now Enforceable in Canada: Who Must Comply and What Happens If You Don’t?
Front-of-Package Nutrition Labelling Is Now Enforceable in Canada: Who Must Comply and What Happens If You Don’t?
By
Abstract Canada’s Front-of-Package (FOP) nutrition labelling requirements are now fully enforceable. Since January 1, 2026, most prepackaged foods imported, manufactured, or packaged at retail in Canada must display the prescribed […] Read More >>

14

Jul 2026

cGMP vs GMP: Key Differences for Dietary Supplements and NHPs
cGMP vs GMP: Key Differences for Dietary Supplements and NHPs
By
Abstract Good Manufacturing Practices are fundamental to product quality in both the Canadian Natural Health Product and U.S. dietary supplement industries. However, the requirements are not interchangeable. In the United […] Read More >>

09

Jul 2026

Health Canada Red Tape Reduction Initiative: NHP Survey
Health Canada Red Tape Reduction Initiative: NHP Survey
By
Abstract Introduction Health Canada’s Red Tape Reduction Initiative for Natural Health Products represents the latest step in the modernization of Canada’s NHP regulatory framework. The proposed amendments are intended to […] Read More >>

26

Jun 2026

AI Hallucinations: Why Regulators Are Paying Attention
AI Hallucinations: Why Regulators Are Paying Attention
By
Regulatory and oversight concern around AI hallucinations is not centered only on intentional misuse, but on the introduction of unverifiable, unsupported, or fabricated information into regulated workflows. As organizations increasingly […] Read More >>

26

Jun 2026

FDA QMSR Requirements in 2026: What Medical Device Manufacturers Need to Know
FDA QMSR Requirements in 2026: What Medical Device Manufacturers Need to Know
By
On February 2, 2026, the FDA’s revised Quality Management System Regulation (QMSR) officially became effective, replacing the long-standing Quality System (QS) Regulation framework under 21 CFR Part 820. While the […] Read More >>

26

Jun 2026

Health Canada Finalizes Phase 2 MDEL Modernization: What Importers Need to Know
Health Canada Finalizes Phase 2 MDEL Modernization: What Importers Need to Know
By
Health Canada has finalized the second phase of its modernization of the Medical Device Establishment Licence (MDEL) framework, publishing amendments to the Medical Devices Regulations in the Canada Gazette, Part […] Read More >>

17

Jun 2026

Health Canada Removes FPS Submission Requirement for NHP Applications
Health Canada Removes FPS Submission Requirement for NHP Applications
By
Health Canada has released Natural Health Product Licensing Bulletin No.11 introducing a significant operational change to the way Finished Product Specifications (FPS) are handled for Natural Health Product (NHP) product […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions